1. Home
  2. RES vs IMTX Comparison

RES vs IMTX Comparison

Compare RES & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$6.38

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

IMTX

Immatics N.V.

HOLD

Current Price

$9.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
IMTX
Founded
1984
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
RES
IMTX
Price
$6.38
$9.35
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$5.64
$19.00
AVG Volume (30 Days)
1.3M
541.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$41,919,000,000.00
N/A
Revenue This Year
$3.29
N/A
Revenue Next Year
$4.05
$25.91
P/E Ratio
$106.67
N/A
Revenue Growth
2216.21
N/A
52 Week Low
$4.18
$5.05
52 Week High
$8.16
$12.41

Technical Indicators

Market Signals
Indicator
RES
IMTX
Relative Strength Index (RSI) 56.66 53.55
Support Level $5.38 $9.37
Resistance Level $6.59 $10.41
Average True Range (ATR) 0.20 0.43
MACD 0.01 0.05
Stochastic Oscillator 60.16 73.42

Price Performance

Historical Comparison
RES
IMTX

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: